KINGDON CAPITAL MANAGEMENT, L.L.C. - 03 Jul 2025 SCHEDULE 13G Report for Jasper Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (JSPR)

Filing Manager
KINGDON CAPITAL MANAGEMENT, L.L.C.
Reporting Manager
KINGDON CAPITAL MANAGEMENT, L.L.C.
Security
Jasper Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share
Symbol
JSPR
Shares outstanding
15,000,000 shares
Disclosed Ownership
765,000 shares
Ownership
5.1%
Form type
SCHEDULE 13G
Filing time
11 Jul 2025, 12:30:10 UTC
Date of event
03 Jul 2025
Next filing
12 Nov 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"KINGDON CAPITAL MANAGEMENT, L.L.C. disclosed 5.1% ownership in Jasper Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (JSPR) on 03 Jul 2025."

Quick Takeaways

  • KINGDON CAPITAL MANAGEMENT, L.L.C. filed SCHEDULE 13G for Jasper Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (JSPR).
  • Disclosed ownership: 5.1%.
  • Date of event: 03 Jul 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 11 Jul 2025, 12:30.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
KINGDON CAPITAL MANAGEMENT, L.L.C. 5.1% 765,000 0 765,000 By: /s/ Richard Weinstein Richard Weinstein / Chief Operating Officer & General Counsel
Mark Kingdon 5.1% 765,000 0 765,000 By: /s/ Mark Kingdon Mark Kingdon

Sponsored